EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

F. Broglio, F. Boutignon, A. Benso, C. Gottero, F. Prodam, E. Arvat, C. Ghè, F. Catapano, A. Torsello, V. Locatelli, G. Muccioli, D. Boeglin, V. Guerlavais, J. A. Fehrentz, J. Martinez, Ezio Ghigo, R. Deghenghi

Research output: Contribution to journalArticlepeer-review

Abstract

EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 μg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.

Original languageEnglish
Pages (from-to)RC26-RC28
JournalJournal of Endocrinological Investigation
Volume25
Issue number8
DOIs
Publication statusPublished - Sept 2002
Externally publishedYes

Keywords

  • GH
  • Ghrelin receptors
  • Humans
  • Oral administration
  • Synthetic GH secretagogues

Fingerprint

Dive into the research topics of 'EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man'. Together they form a unique fingerprint.

Cite this